While a California bill that called for increased antitrust scrutiny of many healthcare private equity transactions was recently vetoed by the governor, state legislatures are likely to continue introducing similar laws, particularly if the Trump-Vance administration eases federal enforcement, write Morgan Lewis lawyers in an article for Law360.